Search
Information provided to WHO by AstraZeneca, the genuine manufacturer of IMFINZI, has confirmed that the products identified in this Alert are falsified. Laboratory analysis of samples of the falsified IMFINZI have been carried out by AstraZeneca. The analysis confirmed that the vials of the falsified product contained no active pharmaceutical ingredient.
Read More
WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.
Read More
As prescription medications containing fentanyl and other illegal substances are becoming more widely accessible worldwide, a global crackdown on illicit drug precursors is leading cartels to experiment with the contents of their products.
Read More
United States District Court Southern District of New York USA v Rui-Siang Lin Money Judgment Filed December 16, 2024 Read the document.
Read More
United States District Court Southern District of New York USA v Rui-Siang Lin Complaint Filed January 26, 2024 Read the document.
Read More
United States District Court Southern District of New York USA v Rui-Siang Lin Indictment Filed March 26, 2024 Read the document.
Read More
FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.
Read More
Prescription Drug Affordability Board Activity through December 18, 2024 Activities Summary Colorado: The Prescription Drug Affordability Board (PDAB) met on December 6, 2024 to hear and discuss public comment before proposing and approving revisions to policy and procedures around affordability reviews. The PDAB updated the state’s Prescription Drug Affordability Review Board and Advisory Council (PDAAC) on December 12, 2024. Maryland:…
Read More
Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.
Read More
The lawsuit against Snap may proceed and the ADA issued a statement about compounded GLP-1 medicines.
Read More